logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
19/11/2025
Musk: In fact, the Grok 4.1 version is a major update.
Latest
1 m ago
Bank of England Monetary Policy Committee member Ding Geli: After the new crown epidemic, we were too optimistic about our expectations for consumption.
2 m ago
Bank of England Monetary Policy Committee member Dingra: Since the outbreak of the new coronavirus, data collection has become increasingly difficult, while supply-side shocks have defined the current state of the world.
2 m ago
After the Food and Drug Administration approved the drug for treating genetic diseases, the stock price of Arrowhead Pharmaceuticals rose by 7.4%.
3 m ago
Bank of England Monetary Policy Committee member Dingra: Although actual wage growth is similar to peers, consumption performance lags behind peers.
4 m ago
Shares of American pharmaceutical company Arrowhead rose by 7.4% after the US Food and Drug Administration approved its drug for a certain genetic disease.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.